Showing posts with label Asbestos Lung. Show all posts
Showing posts with label Asbestos Lung. Show all posts

Wednesday, January 2, 2008

Qld cancer patient welcomes drug subsidy

A Maryborough cancer sufferer has welcomed the placing of a chemotherapy drug onto the Pharmaceutical Benefits Scheme (PBS) this week.

In 1995, 65-year-old Gary Morse was diagnosed with an incurable lung cancer.

He says the chemotherapy and asbestos cancer drug, Alimta, helped him greatly last year.

But he say it would have cost him about $20,000 if his oncologist had not persuaded a private health insurer to pay the cost.

"We have private insurance and he [the oncologist] got in contact with them and got them to agree to pay for the first three treatments and the results were great," he said.

"Then he talked them into paying for the next one and of course now it's come onto the free list, which is better still.

"If we hadn't had private insurance we would have had to take it out of our superannuation retirement fund.

"I know of another one person who's on it, and it's increased his life span, and of course it's also going to increase mine too.

"This year 22 of our family were all together for Christmas, the first time ever, and I thought it was going to be the 'last supper', actually, until this new drug come on the scene.

"Now we can look forward to the future. I'm really pleased with it."

Source

Monday, November 12, 2007

Asbestos illnesses cost H&W £30m in compensation

MORE than £30 million pounds in compensation has been paid out to Harland & Wolff employees for asbestos-related illnesses.

As many as 2,693 employees have shared the £30,273,903 compensation since 2001.

But the compensation payout has only allowed employees to receive around £11,241.70 each.

Former Trade Minister Sir Reg Empey agreed in March 2002 to guarantee compensation for ex-shipyard staff.

According to figures also acquired in an Assembly question by DUP MLA Peter Weir, as many as 515 people have died in the last 10 years as a consequence of asbestos-related illnesses contracted through exposure to asbestos in their workplace during the previous decade.

In his Assembly response, the Minister of Enterprise, Trade and Investment, Nigel Dodds, said asbestos- related diseases are in the main "occupationally acquired and include asbestosis, mesothelioma and lung cancer".

It is pointed out that the number of deaths caused by asbestos-related lung cancer is not available.

But it was revealed that the number of deaths from asbestos-related lung cancer may equal those caused by mesothelioma – 439.


In his response Minister Dodds said Harland & Wolff was taken into public ownership in 1975.

"Harland & Wolff plc (H&W plc) remained in public ownership at the time of the privatisation of the shipbuilding business in 1989. All liabilities that existed at this time were retained in H&W plc," he said.

"DETI has guaranteed funding to H&W plc to enable it to meet liabilities as they fall due.

"This commitment covers funding to meet obligations that would fall to the company in relation to agreed compensation claims from employees who contracted asbestos-related illnesses. This position was affirmed in a statement to the Northern Ireland Assembly on 5 March 2002 by Sir Reg Empey, the then DETI Minister."

The news comes as campaigners warn that asbestos disease-linked deaths are at epidemic levels and could become worse in coming decades.

With 515 people dying in the last 10 years the Justice for Asbestos Victims' (JAV) spokeswoman, Fiona Sterritt, has warned greater heartache lies ahead for victims and their families.

She said: "There is no doubt that it is an epidemic. There are people who were working with it on a daily basis into the 1990s. "Anybody putting a noticeboard in a school could have been exposed to it. There is a latency there."

It takes years for asbestos-linked conditions like mesothelioma or lung cancer to develop. JAV was established in 2002 by sufferers and the families of those who died from the diseases.

Ms Sterritt added people like plumbers and electricians had been badly affected. "Everything built before the 1970s likely had some form of asbestos and it can take 30-40 years to develop," she added.

Lobbyists have predicted about 10,000 deaths a year across the UK. Most of those now suffering with asbestos-related diseases were exposed to asbestos between the 1940s and 1970s.

Health Minister Michael McGimpsey told Mr Weir that he was committed to helping those affected.

"This will include health promotion awareness as well as provision of the full range of primary, secondary and community care services appropriate to the respiratory and oncology illnesses commonly associated with asbestos exposure," he said.

In the Assembly Question, Trade Minister Nigel Dodds, revealed there were 53 deaths last year, up on 42 in 1997. In 2004 a total of 65 people passed away.

SOURCE

Tuesday, October 16, 2007

Asbestos Exposure: How Risky Is It?

The hazard, exposure, and risks associated with asbestos fibers have been explored and debated for many years. Human evidence suggests an association between exposure to asbestos and asbestosis, lung cancer, and mesothelioma, although the lack of consistent information on fiber type, size, and exposure concentrations and duration limit our ability to establish causal relationships between exposure and disease in some cases. While uncertainties remain in our ability to consistently and accurately quantify asbestos risk to humans, progress has been made in characterizing those key factors, namely hazard and exposure, that are critical to an assessment of health risk.

Because asbestos is a natural material, there will always be some background or ambient exposure to humans. Although mining and commercial applications have diminished in some parts of the world, asbestos continues to have commercial applications, and hence, there remains exposure potential from these sources. Chrysotile and amphibole asbestos are the types most commonly used and hence studied experimentally, and it has become increasingly clear that they differ with respect to toxicity and disease potential. This has been demonstrated in animal models, which appear to be reflective of the human situation as well.

Progress on a number of fronts has led to general scientific consensus on the following: (1) amphibole fibers (which tend to be relatively long and thin) are a more potent risk factor for the development of mesothelioma and, to a lesser degree, lung cancer than are chrysotile fibers (which tend to be relatively short and wide); (2) longer, thin fibers are more pathogenic and there appear to be fiber size thresholds below which asbestos fibers do not pose any threat; and (3) those animal studies in which high exposure concentrations resulted in lung overloading are not considered relevant to humans.

Analysis of the epidemiological literature supports some common patterns including:
(1) for occupational and industrial exposures, the weight of evidence does not consistently support causal relationships between asbestos exposure and onset of pulmonary disease, some studies showing associative relationships but others showing no relationship between exposure and disease onset; and (2) chrysotile alone, uncontaminated by other fiber types, particularly amphiboles, does not appear to be a risk factor for mesothelioma, as once thought.

Advances in risk assessment methodology and analytical techniques, together with reevaluation of historical data, reveal that the current Environmental Protection Agency (EPA) approach for risk assessment of asbestosis is not in step with current scientific consensus, particularly for chrysotile fibers. In recent years, new knowledge about how asbestos risk can be more accurately and quantitatively determined has been generated. There is thus a scientific basis for adoption of these methods by regulatory agencies, including the EPA. While occupational exposures to asbestos remain and should be vigilantly monitored, there appears to be no compelling scientific evidence that ambient exposure to chrysotile asbestos poses a significant health risk.


SOURCE

Monday, October 15, 2007

October has been designated Healthy Lung Month

The smell of burning leaves, an apple pie baking in the oven, or a wood fire in a neighbor's fireplace often evoke memories of special people and experiences from past autumns. While we may be mindful of inhaling deeply to enjoy these scents, we seldom give thought to what happens to the air we breathe in.

We all know we need the oxygen in the air to live, but unless we experience breathing difficulties, most of us rarely think about our lungs at all.

The lungs are complex organs, considered far more complicated than the heart. They not only take the oxygen from the air and send it into the bloodstream for delivery throughout the body, but the lungs filter out substances like dust, pollen, viruses, and bacteria from the air we breathe. They are also responsible for eliminating waste from the bloodstream. It is clear lung health is important, and October has been designated Healthy Lung Month in recognition of this fact.

If all types of lung disease are combined, it is the 3rd highest cause of death in the United States. Over 35 million Americans live with an ongoing lung disease like asthma or chronic obstructive pulmonary disease (COPD). Lung disease is the cause of 1 in 7 deaths annually in this country.
Unfortunately, it can be easy to overlook early signs of lung disease. At first, many people simply realize they do not have much energy. But as the lung condition worsens, other symptoms become more apparent. Trouble breathing, shortness of breath, reduced ability to exercise, feeling like you are not getting enough air, a chronic cough, coughing up blood or mucus, or pain when inhaling and exhaling, are among the signs of lung disease.

Common lung conditions include:
* Asthma, which affects 20 million Americans. It causes inflammation and swelling of the airways in the lungs. The narrow airways limits the flow of air in and out of the lungs, causing wheezing, coughing, tightness in the chest, and difficulty breathing.

* COPD, which includes emphysema and chronic obstructive bronchitis. Both conditions cause inflammation of the bronchial tubes that carry air to the lungs. This leads to thickening and scarring of the lining of the bronchial tubes and the production of excess mucus, making breathing difficult. COPD is the 4th leading cause of death in the United States.

* Lung cancer, now the leading cause of cancer deaths in American women, is characterized by the abnormal, uncontrolled growth of malignant lung cells.
These cells invade and destroy normal cells in nearby tissues and can spread to other parts of the body.

Fortunately, the risk of developing lung disease can be reduced. First, if you are a smoker, quit. Whether a smoker or a non-smoker, everyone should try to avoid second-hand smoke.
Second, eating a healthy diet, rich in fruits and vegetables, lowers the risk of cancer. Drinking plenty of water helps to replace moisture lost when we exhale, keeping the lung tissue moist and healthy.
Exercise is also important for healthy lungs, stimulating the blood flow required for the lungs to function optimally.
Lung health also benefits from getting vaccinated against the flu every year. Influenza (and pneumonia, often a complication of the flu), damages lung tissue and leads to a number of adverse health effects.
In addition to the above, avoiding environmental hazards such as asbestos and radon is also important in protecting lung health. Protective clothing and a face mask are required for anyone working in a job that entails exposure to asbestos. Radon in the home can be measured with a test kit to determine if remediation is advised.
The Central Connecticut Health District, serving the towns of Berlin, Newington, Rocky Hill, and Wethersfield, sponsors a number of flu shot clinics where pneumonia shots are also available. The Health District also sells low-cost radon test kits. For further information about flu clinics, radon kits, and other public health concerns, contact the Health District at 860-721-2822 (www.ccthd.org). Specific information about lung health and lung disease is available through the American Lung Association at 1-800-548-8252 (www.lungusa.org) and the National Women's Health Information Center at 1-800-994-9662 or 1-888-220-5446 for the hearing impaired (www.4women.gov).

SOURCE